A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

Summary

Study is a multicenter, two-part, open-label phase II study in adults, evaluating the safety and long-term efficacy of PF-06473871 one year after surgical revision and treatment with PF-06473871.

Timeline

Start

2014-12

Primary completion

2015-01

Completion

2015-01

Outcome

Outcome not reported

Stopped: “B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.”

Drugs

Indications